XTX Topco’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-464
Closed -$14.2K 3518
2025
Q3
$14.2K Buy
+464
New +$13.8K ﹤0.01% 2385
2025
Q2
Sell
-729
Closed -$26K 2719
2025
Q1
$26K Sell
729
-1,233
-63% -$48.3K ﹤0.01% 2099
2024
Q4
$64.8K Buy
1,962
+1,085
+124% +$24.8K 0.01% 1855
2024
Q3
$16.1K Buy
+877
New +$17.8K ﹤0.01% 1875
2024
Q1
Sell
-598
Closed -$19.2K 2055
2023
Q4
$19.2K Buy
+598
New +$15.8K ﹤0.01% 1365

Other funds holding ICCM

XTX Topco's ICCM Position: Q4 2025 in Review

XTX Topco sold out of IceCure Medical (ICCM) in Q4 2025, closing a stake of 464 shares — an estimated $14.2K sold.

XTX Topco first reported a position in ICCM in Q4 2023 and held it in 5 quarters. The position peaked at $64.8K in Q4 2024. 18 funds tracked by Wall St. Rank hold ICCM as of Q4 2025.

  • XTX Topco reported no remaining IceCure Medical position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 464 IceCure Medical shares in Q4 2025, an estimated $14.2K.
  • XTX Topco first reported a position in IceCure Medical in Q4 2023 and held it in 5 quarters.
  • XTX Topco's IceCure Medical position peaked at $64.8K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held IceCure Medical as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.